Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription coactivator activity	NCOA2 KDM4C PPRC1 WWTR1 SSBP3 ARID1A PPARGC1A KMT2C BRDT NCOA1 TADA2A MAML2	2.09e-06	303	144	12	GO:0003713
GeneOntologyMolecularFunction	transcription coregulator activity	NCOA2 IRF2BP2 KDM4C PPRC1 WWTR1 KCTD1 BCOR SSBP3 ARID1A NCOA5 PPARGC1A KMT2C BRDT NCOA1 TADA2A MAML2	3.10e-06	562	144	16	GO:0003712
GeneOntologyMolecularFunction	nuclear receptor coactivator activity	NCOA2 KDM4C PPRC1 PPARGC1A NCOA1	7.82e-05	61	144	5	GO:0030374
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	NCOA2 IRF2BP2 SYNPO2 FMR1 KDM4C PPRC1 WWTR1 ICE1 KCTD1 BCOR SSBP3 ARID1A NCOA5 PPARGC1A KMT2C BRDT ABI2 NCOA1 TADA2A MAML2	2.53e-04	1160	144	20	GO:0030674
GeneOntologyMolecularFunction	molecular adaptor activity	NCOA2 IRF2BP2 SYNPO2 FMR1 KDM4C PPRC1 WWTR1 ICE1 KCTD1 BCOR SSBP3 ARID1A NCOA5 PPARGC1A KMT2C BRDT ABI2 NCOA1 TADA2A MAML2 CNOT1 KLHL17	2.85e-04	1356	144	22	GO:0060090
GeneOntologyMolecularFunction	nuclear estrogen receptor binding	NCOA2 PPARGC1A NCOA1 CNOT1	5.77e-04	53	144	4	GO:0030331
GeneOntologyCellularComponent	nuclear body	NCOA2 TBXA2R ERCC6 FMR1 EP400 PTPN23 WWTR1 ICE1 ZNF395 PPARGC1A EAF1 NFE2 MAML2 SRRM2 SAP130 RNF111 DYRK3	1.38e-04	903	142	17	GO:0016604
GeneOntologyCellularComponent	glutamatergic synapse	CACNB1 WASL RAB17 FMR1 KALRN SPTBN2 LRRTM1 PLXND1 NRXN3 CELSR3 ABI2 SRGAP3 CLTC CTNND2 KLHL17	4.53e-04	817	142	15	GO:0098978
GeneOntologyCellularComponent	cytoplasmic ribonucleoprotein granule	SMG1 FMR1 PABPC1 DCP1B PABPC3 CNOT1 SAMD4A DYRK3	5.15e-04	269	142	8	GO:0036464
GeneOntologyCellularComponent	transcription elongation factor complex	ERCC6 ICE1 ELL2 EAF1	5.70e-04	56	142	4	GO:0008023
GeneOntologyCellularComponent	mCRD-mediated mRNA stability complex	PABPC1 PABPC3	6.75e-04	6	142	2	GO:0106002
GeneOntologyCellularComponent	ribonucleoprotein granule	SMG1 FMR1 PABPC1 DCP1B PABPC3 CNOT1 SAMD4A DYRK3	7.86e-04	287	142	8	GO:0035770
Domain	Clathrin_H-chain_propeller_rpt	CLTCL1 CLTC	5.58e-05	2	140	2	IPR022365
Domain	Clathrin-link	CLTCL1 CLTC	5.58e-05	2	140	2	PF09268
Domain	-	CLTCL1 CLTC	5.58e-05	2	140	2	2.130.10.110
Domain	Clathrin_heavy_chain	CLTCL1 CLTC	5.58e-05	2	140	2	IPR016341
Domain	Clathrin_H-chain_propeller_N	CLTCL1 CLTC	5.58e-05	2	140	2	IPR001473
Domain	Clathrin_H-chain_link/propller	CLTCL1 CLTC	5.58e-05	2	140	2	IPR016025
Domain	Clathrin_propel	CLTCL1 CLTC	5.58e-05	2	140	2	PF01394
Domain	Clathrin_H-chain_linker_core	CLTCL1 CLTC	5.58e-05	2	140	2	IPR015348
Domain	Clathrin_H-chain_linker	CLTCL1 CLTC	1.67e-04	3	140	2	IPR012331
Domain	DUF1518	NCOA2 NCOA1	1.67e-04	3	140	2	PF07469
Domain	Nuc_rcpt_coact_Ncoa-typ	NCOA2 NCOA1	1.67e-04	3	140	2	IPR014920
Domain	SRC-1	NCOA2 NCOA1	1.67e-04	3	140	2	IPR014935
Domain	Src1_rcpt_coact	NCOA2 NCOA1	1.67e-04	3	140	2	IPR008955
Domain	Nuclear_rcpt_coactivator	NCOA2 NCOA1	1.67e-04	3	140	2	IPR017426
Domain	-	NCOA2 NCOA1	1.67e-04	3	140	2	4.10.630.10
Domain	DUF1518	NCOA2 NCOA1	1.67e-04	3	140	2	IPR010011
Domain	DUF1518	NCOA2 NCOA1	1.67e-04	3	140	2	SM01151
Domain	CLH	CLTCL1 CLTC	1.67e-04	3	140	2	SM00299
Domain	SRC-1	NCOA2 NCOA1	1.67e-04	3	140	2	PF08832
Domain	Nuc_rec_co-act	NCOA2 NCOA1	1.67e-04	3	140	2	PF08815
Domain	Znf_RING	MARCHF10 MARCHF9 CUL9 RNF43 MEX3C RNF214 KMT2C TRIM36 SH3RF3 RNF111	1.77e-04	326	140	10	IPR001841
Domain	PolyA	PABPC1 PABPC3	5.50e-04	5	140	2	SM00517
Domain	-	PABPC1 PABPC3	5.50e-04	5	140	2	1.10.1900.10
Domain	PABP	PABPC1 PABPC3	5.50e-04	5	140	2	PF00658
Domain	PABP_1234	PABPC1 PABPC3	5.50e-04	5	140	2	IPR006515
Domain	PABC	PABPC1 PABPC3	5.50e-04	5	140	2	PS51309
Domain	PABP_HYD	PABPC1 PABPC3	5.50e-04	5	140	2	IPR002004
Domain	-	TCF19 MARCHF10 KDM4C MARCHF9 RNF43 MEX3C RNF214 KMT2C TRIM36 SH3RF3 RNF111	5.77e-04	449	140	11	3.30.40.10
Domain	Znf_RING/FYVE/PHD	TCF19 MARCHF10 KDM4C MARCHF9 RNF43 MEX3C RNF214 KMT2C TRIM36 SH3RF3 RNF111	6.92e-04	459	140	11	IPR013083
Domain	Nuc_rcpt_coact	NCOA2 NCOA1	8.20e-04	6	140	2	IPR009110
Domain	PAS	NCOA2 NPAS3 NCOA1	8.40e-04	25	140	3	PF00989
Domain	PAS_fold	NCOA2 NPAS3 NCOA1	8.40e-04	25	140	3	IPR013767
Domain	Clathrin	CLTCL1 CLTC	1.14e-03	7	140	2	PF00637
Domain	CHCR	CLTCL1 CLTC	1.14e-03	7	140	2	PS50236
Domain	SH3	CACNB1 RASA1 MYO1E KALRN ABI2 SRGAP3 SH3RF3	1.23e-03	216	140	7	SM00326
Domain	SH3	CACNB1 RASA1 MYO1E KALRN ABI2 SRGAP3 SH3RF3	1.23e-03	216	140	7	PS50002
Domain	SH3_domain	CACNB1 RASA1 MYO1E KALRN ABI2 SRGAP3 SH3RF3	1.37e-03	220	140	7	IPR001452
Domain	SH3_1	CACNB1 RASA1 MYO1E ABI2 SRGAP3 SH3RF3	1.49e-03	164	140	6	PF00018
Domain	Clathrin_H-chain/VPS_repeat	CLTCL1 CLTC	1.52e-03	8	140	2	IPR000547
Domain	PAS	NCOA2 NPAS3 NCOA1	1.74e-03	32	140	3	SM00091
Domain	ZF_RING_2	CUL9 RNF43 MEX3C RNF214 KMT2C TRIM36 SH3RF3 RNF111	1.86e-03	298	140	8	PS50089
Domain	Znf_C3HC4_RING-type	MARCHF10 MARCHF9 RNF43 MEX3C TRIM36 RNF111	1.90e-03	172	140	6	IPR018957
Domain	PAS	NCOA2 NPAS3 NCOA1	2.08e-03	34	140	3	PS50112
Domain	PAS	NCOA2 NPAS3 NCOA1	2.08e-03	34	140	3	IPR000014
Domain	RING	CUL9 RNF43 MEX3C RNF214 KMT2C TRIM36 SH3RF3 RNF111	2.14e-03	305	140	8	SM00184
Domain	Protein_kinase_ATP_BS	CDK17 KALRN CIT MAP3K4 AURKC SIK2 ULK1 ALK DYRK3	2.26e-03	379	140	9	IPR017441
Pathway	REACTOME_RAC1_GTPASE_CYCLE	WASL KALRN TAGAP CIT ABI2 SRGAP3 DOCK6 WIPF2	4.18e-05	184	98	8	M41809
Pathway	REACTOME_ALK_MUTANTS_BIND_TKIS	EML4 CLTC ALK	6.85e-05	12	98	3	M42522
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	CLTCL1 EP400 MYO1E KALRN PPRC1 CUL9 IRF5 ICE1 ZNF395 PLXND1 REV3L COMTD1 ARID1A CIT RNF43 KMT2C EHBP1L1 CELSR3 PTPRF ULK1 ESPL1 DOCK6 MYRF BAHCC1 KLHL17	6.54e-12	1105	146	25	35748872
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SLAIN2 SMG1 RELCH EP400 TRIOBP ICE1 PLXND1 BCOR NCAPH KMT2C NRXN3 CELSR3 TMX4 MAML2 ESPL1 DOCK6 CNOT1	1.06e-10	529	146	17	14621295
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	NCOA2 IRF2BP2 SMG1 FMR1 DHX40 MUC16 REV3L BCOR ARID1A CCDC85A CEP350 EHBP1L1 PITPNM3 NCOA1 CTNND2 CNOT1 FAM149A	1.81e-09	638	146	17	31182584
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	NCOA2 WASL MYO1E KALRN CORO2A KDM4C PPRC1 SPTBN2 DNER TRIOBP CUL9 REV3L ARID1A CIT CCDC85A CEP350 FAM120A CELSR3 OTOF CLTC NAV3 CTNND2 RNF111	4.55e-09	1285	146	23	35914814
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NCOA2 SLAIN2 EP400 SPTBN2 BAG3 PTPN23 WWTR1 BCOR ARID1A NCAPH KMT2C CLTC CLINT1 SAP130 CNOT1	1.24e-08	549	146	15	38280479
Pubmed	A human MAP kinase interactome.	WASL SYNPO2 SPTBN2 BAG3 PTPN23 WWTR1 LCP2 MAP3K4 CEP350 KMT2C CLTC NAV3 WIPF2 RNF111	2.02e-08	486	146	14	20936779
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SLAIN2 CDK17 BAG3 RALGAPB SPATA18 WWTR1 PABPC1 MEX3C SHKBP1 CEP350 DCP1B KIAA1217 SIK2 CLINT1 SRRM2 DOCK6 SH3RF3 SAMD4A	2.51e-08	861	146	18	36931259
Pubmed	Human transcription factor protein interaction networks.	NCOA2 IRF2BP2 SMG1 EP400 DHX40 CUL9 IRF5 BCOR SSBP3 ARID1A CIT PABPC1 RNF214 KMT2C FAM120A DCP1B PABPC3 NCOA1 TADA2A SRRM2 SAP130 CNOT1 FILIP1L	3.23e-08	1429	146	23	35140242
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NCOA2 CACNB1 FMR1 KALRN SPTBN2 TRIOBP LRRTM1 BCOR CIT PABPC1 FAM120A ABI2 SRGAP3 PABPC3 KIAA1217 CLTC CTNND2 CNOT1	1.34e-07	963	146	18	28671696
Pubmed	Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells.	NCOA2 PPARGC1A NCOA1	2.89e-07	4	146	3	17513608
Pubmed	Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.	SLAIN2 IRF2BP2 WASL PABPC1 SHKBP1 SRRM2 WIPF2	3.89e-07	108	146	7	19531213
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	RELCH SPTBN2 BAG3 RALGAPB TRIOBP PTPN23 BCOR ARID1A SHKBP1 NCOA5 CEP350 PTPRF ABI2 CLTC CLINT1 TRIM36 SRRM2 CNOT1	4.66e-07	1049	146	18	27880917
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	NCOA2 IRF2BP2 MYO1E WWTR1 BCOR ARID1A NUP35 NCOA5 KMT2C DCP1B SAP130 CNOT1	5.78e-07	457	146	12	32344865
Pubmed	Identification of COUP-TFII orphan nuclear receptor as a retinoic acid-activated receptor.	NCOA2 PPARGC1A NCOA1	7.20e-07	5	146	3	18798693
Pubmed	A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes.	NCOA2 PPARGC1A NCOA1	7.20e-07	5	146	3	15026545
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	NCOA2 IRF2BP2 EP400 BCOR ARID1A SAP130	1.43e-06	83	146	6	28794006
Pubmed	A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1alpha, prevents triglyceride accumulation, and potentiates insulin signaling in vitro.	NCOA2 PPARGC1A NCOA1	1.44e-06	6	146	3	16373399
Pubmed	NMD abnormalities during brain development in the Fmr1-knockout mouse model of fragile X syndrome.	FMR1 PABPC1 PABPC3	2.51e-06	7	146	3	34784943
Pubmed	A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.	EP400 BCOR ARID1A KMT2C KIAA1217 SAP130 CNOT1	2.96e-06	146	146	7	23892456
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	SLAIN2 CCHCR1 WASL DYNC2I2 TROAP DHX40 SPTBN2 PTPN23 CEP350 FAM120A ABI2 KIAA1217 CLINT1 CNOT1 JPT2	3.34e-06	853	146	15	28718761
Pubmed	Identification of the antibiotic ionomycin as an unexpected peroxisome proliferator-activated receptor γ (PPARγ) ligand with a unique binding mode and effective glucose-lowering activity in a mouse model of diabetes.	NCOA2 PPARGC1A NCOA1	4.00e-06	8	146	3	23178929
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	NCOA2 SLAIN2 IRF2BP2 EP400 BCOR ARID1A CIT PABPC1 KMT2C FAM120A CLTC NCOA1 CLINT1 SRRM2 SAP130 CNOT1 RASGRP2	4.19e-06	1103	146	17	34189442
Pubmed	Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	CORO2A ICE1 CIT NAV3 MYRF CNOT1	4.77e-06	102	146	6	10231032
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	SLAIN2 ERCC6 FMR1 EP400 CUL9 REV3L BCOR ARID1A RNF43 AURKC EAF1 FAM120A BRDT TADA2A SRRM2 SAP130 BAHCC1	4.89e-06	1116	146	17	31753913
Pubmed	Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	SLAIN2 RELCH EP400 PTPN23 KMT2C BAHCC1	5.05e-06	103	146	6	10819331
Pubmed	BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates.	CLTCL1 TRIOBP WWTR1 ZNF395 FAM120A DCP1B CLTC CNOT1	5.48e-06	226	146	8	25900982
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	EML4 BAG3 ZNF395 BCOR PABPC1 FAM120A CLTC SIK2	6.64e-06	232	146	8	25515538
Pubmed	The protein interaction landscape of the human CMGC kinase group.	SLAIN2 CDK17 CACNB1 ERCC5 MARCHF10 EP400 TROAP ICE1 PABPC1 CEP350 AURKC SRRM2 DYRK3	8.09e-06	695	146	13	23602568
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	SLAIN2 CDK17 DYNC2I2 PABPC1 MEX3C SHKBP1 CEP350 EAF1 DCP1B KIAA1217 SIK2 CLINT1 ESPL1 DOCK6 CNOT1 SAMD4A	8.18e-06	1038	146	16	26673895
Pubmed	The core component of the mammalian SWI/SNF complex SMARCD3/BAF60c is a coactivator for the nuclear retinoic acid receptor.	NCOA2 ARID1A NCOA1	8.51e-06	10	146	3	17363140
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	EP400 PPRC1 RALGAPB CUL9 MAP3K4 SRGAP3 CLTC NAV3 ULK1 SRRM2	9.30e-06	407	146	10	12693553
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	IRF2BP2 WASL EP400 DHX40 ARID1A PABPC1 CLTC TADA2A SRRM2 WIPF2 JPT2	1.04e-05	506	146	11	30890647
Pubmed	Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.	WASL RASA1 EML4 BAG3 PABPC1 FAM120A DCP1B ALK DYRK3	1.08e-05	327	146	9	15592455
Pubmed	The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome.	NCOA2 PPARGC1A NCOA1	1.17e-05	11	146	3	36613751
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	WASL FMR1 MYO1E EML4 TRIOBP PABPC1 CEP350 RNF214 FAM120A CLINT1 ESPL1 CNOT1 JPT2	1.25e-05	724	146	13	36232890
Pubmed	The little elongation complex regulates small nuclear RNA transcription.	ICE1 ELL2 EAF1	1.55e-05	12	146	3	22195968
Pubmed	Exon scanning by reverse transcriptase-polymerase chain reaction for detection of known and novel EML4-ALK fusion variants in non-small cell lung cancer.	EML4 ALK	1.75e-05	2	146	2	21356191
Pubmed	Clinicopathological and Prognostic Significance of the EML4-ALK Translocation and IGFR1, TTF1, Napsin A Expression in Patients with Lung Adenocarcinoma.	EML4 ALK	1.75e-05	2	146	2	32876329
Pubmed	Malignant pleural mesothelioma with an EML4-ALK fusion: Expect the unexpected!	EML4 ALK	1.75e-05	2	146	2	35074700
Pubmed	EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer.	EML4 ALK	1.75e-05	2	146	2	18594010
Pubmed	EML4-ALK induces epithelial-mesenchymal transition consistent with cancer stem cell properties in H1299 non-small cell lung cancer cells.	EML4 ALK	1.75e-05	2	146	2	25735977
Pubmed	EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with wild-type EGFR.	EML4 ALK	1.75e-05	2	146	2	22124476
Pubmed	EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues.	EML4 ALK	1.75e-05	2	146	2	19147828
Pubmed	Targeting stemness is an effective strategy to control EML4-ALK+ non-small cell lung cancer cells.	EML4 ALK	1.75e-05	2	146	2	26517679
Pubmed	SRC-1 and TIF2 control energy balance between white and brown adipose tissues.	NCOA2 NCOA1	1.75e-05	2	146	2	12507421
Pubmed	Circular RNA F-circEA-2a derived from EML4-ALK fusion gene promotes cell migration and invasion in non-small cell lung cancer.	EML4 ALK	1.75e-05	2	146	2	30236141
Pubmed	A novel mechanism of EML4-ALK rearrangement mediated by chromothripsis in a patient-derived cell line.	EML4 ALK	1.75e-05	2	146	2	25144242
Pubmed	EML4-ALK fusion transcript is not found in gastrointestinal and breast cancers.	EML4 ALK	1.75e-05	2	146	2	18414414
Pubmed	Polymorphisms of DNA repair-related genes with susceptibility and prognosis of prostate cancer.	ERCC5 ERCC6	1.75e-05	2	146	2	24615090
Pubmed	Investigation on the prognostic impact of concurrent genomic alterations in crizotinib-treated EML4-ALK-rearranged advanced non-small cell lung cancer patients.	EML4 ALK	1.75e-05	2	146	2	32563740
Pubmed	Effective enrichment strategy for EML4-ALK fusion gene screening in patients with non-small cell lung cancer.	EML4 ALK	1.75e-05	2	146	2	24388371
Pubmed	Circular RNA F-circEA produced from EML4-ALK fusion gene as a novel liquid biopsy biomarker for non-small cell lung cancer.	EML4 ALK	1.75e-05	2	146	2	29628502
Pubmed	The promoter of the Poly(A) binding protein 2 (Pabp2) retroposon is derived from the 5'-untranslated region of the Pabp1 progenitor gene.	PABPC1 PABPC3	1.75e-05	2	146	2	10534404
Pubmed	New insights into anaplastic lymphoma kinase-positive nonsmall cell lung cancer.	EML4 ALK	1.75e-05	2	146	2	29199691
Pubmed	Semaphorin4A-Plexin D1 Axis Induces Th2 and Th17 While Represses Th1 Skewing in an Autocrine Manner.	PLXND1 SEMA4A	1.75e-05	2	146	2	32971928
Pubmed	Partially redundant functions of SRC-1 and TIF2 in postnatal survival and male reproduction.	NCOA2 NCOA1	1.75e-05	2	146	2	15070739
Pubmed	Gender and cell-type-specific effects of the transcription-coupled repair protein, ERCC6/CSB, on repeat expansion in a mouse model of the fragile X-related disorders.	ERCC6 FMR1	1.75e-05	2	146	2	24352881
Pubmed	Thyroid function in mice with compound heterozygous and homozygous disruptions of SRC-1 and TIF-2 coactivators: evidence for haploinsufficiency.	NCOA2 NCOA1	1.75e-05	2	146	2	11897715
Pubmed	Differential protein stability and clinical responses of EML4-ALK fusion variants to various ALK inhibitors in advanced ALK-rearranged non-small cell lung cancer.	EML4 ALK	1.75e-05	2	146	2	28039177
Pubmed	Pulmonary inflammatory myofibroblastic tumor harboring EML4-ALK fusion gene.	EML4 ALK	1.75e-05	2	146	2	24277751
Pubmed	Distinct steady-state nuclear receptor coregulator complexes exist in vivo.	NCOA2 NCOA1	1.75e-05	2	146	2	9751728
Pubmed	Super-enhancer-driven IRF2BP2 enhances ALK activity and promotes neuroblastoma cell proliferation.	IRF2BP2 ALK	1.75e-05	2	146	2	38864832
Pubmed	Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer.	EML4 ALK	1.75e-05	2	146	2	26544515
Pubmed	Nucleotide sequence of a mouse testis poly(A) binding protein cDNA.	PABPC1 PABPC3	1.75e-05	2	146	2	1630930
Pubmed	Ncoa2 Promotes CD8+ T cell-Mediated Antitumor Immunity by Stimulating T-cell Activation via Upregulation of PGC-1α Critical for Mitochondrial Function.	NCOA2 PPARGC1A	1.75e-05	2	146	2	37540802
Pubmed	EML4-ALK fusion lung cancer: a rare acquired event.	EML4 ALK	1.75e-05	2	146	2	18320074
Pubmed	EML4-ALK translocation in both metachronous second primary lung sarcomatoid carcinoma and lung adenocarcinoma: a case report.	EML4 ALK	1.75e-05	2	146	2	23664446
Pubmed	EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers.	EML4 ALK	1.75e-05	2	146	2	18166835
Pubmed	Identification of anaplastic lymphoma kinase fusions in clear cell renal cell carcinoma.	EML4 ALK	1.75e-05	2	146	2	32020234
Pubmed	Hepatic SRC-1 activity orchestrates transcriptional circuitries of amino acid pathways with potential relevance for human metabolic pathogenesis.	NCOA2 NCOA1	1.75e-05	2	146	2	25148457
Pubmed	Identification of a EML4-ALK exon 19 fusion variant in lung adenocarcinoma and alectinib resistance.	EML4 ALK	1.75e-05	2	146	2	34391065
Pubmed	EML4-ALK fusion variant V3 is a high-risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ non-small cell lung cancer.	EML4 ALK	1.75e-05	2	146	2	29363116
Pubmed	Developmental expression of poly(A) binding protein mRNAs during spermatogenesis in the mouse.	PABPC1 PABPC3	1.75e-05	2	146	2	7893484
Pubmed	Coupling an EML4-ALK-centric interactome with RNA interference identifies sensitizers to ALK inhibitors.	EML4 ALK	1.75e-05	2	146	2	27811184
Pubmed	Characterization of two cytoplasmic poly(A)-binding proteins, PABPC1 and PABPC2, in mouse spermatogenic cells.	PABPC1 PABPC3	1.75e-05	2	146	2	19020299
Pubmed	Characterization of a second human clathrin heavy chain polypeptide gene (CLH-22) from chromosome 22q11.	CLTCL1 CLTC	1.75e-05	2	146	2	8733129
Pubmed	A rare case of an EML4-ALK-rearranged lung adenocarcinoma missed by in situ-hybridization but detected by RT-PCR.	EML4 ALK	1.75e-05	2	146	2	25028527
Pubmed	PGC-1 coactivators: inducible regulators of energy metabolism in health and disease.	PPRC1 PPARGC1A	1.75e-05	2	146	2	16511594
Pubmed	Second Primary Lung Adenocarcinoma Harboring EML4-ALK After Surgically Resected EGFR Positive Lung Adenocarcinoma.	EML4 ALK	1.75e-05	2	146	2	26704814
Pubmed	Preselection based on clinical characteristics in German non-small-cell lung cancer patients screened for EML4-ALK translocation.	EML4 ALK	1.75e-05	2	146	2	24346098
Pubmed	Phase-separated foci of EML4-ALK facilitate signalling and depend upon an active kinase conformation.	EML4 ALK	1.75e-05	2	146	2	34661367
Pubmed	Glycometabolic reprogramming-mediated proangiogenic phenotype enhancement of cancer-associated fibroblasts in oral squamous cell carcinoma: role of PGC-1α/PFKFB3 axis.	PFKFB3 PPARGC1A	1.75e-05	2	146	2	35444287
Pubmed	Functional compensation for the loss of testis-specific poly(A)-binding protein, PABPC2, during mouse spermatogenesis.	PABPC1 PABPC3	1.75e-05	2	146	2	26971890
Pubmed	Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.	EML4 ALK	1.75e-05	2	146	2	18927303
Pubmed	EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas.	EML4 ALK	1.75e-05	2	146	2	18242762
Pubmed	CHC22 and CHC17 clathrins have distinct biochemical properties and display differential regulation and function.	CLTCL1 CLTC	1.75e-05	2	146	2	29097553
Pubmed	Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer.	EML4 ALK	1.75e-05	2	146	2	18593892
Pubmed	Expanded Circulating Tumor Cells from a Patient with ALK-Positive Lung Cancer Present with EML4-ALK Rearrangement Along with Resistance Mutation and Enable Drug Sensitivity Testing: A Case Study.	EML4 ALK	1.75e-05	2	146	2	27507192
Pubmed	The impact of the ALK fusion variant on clinical outcomes in EML4-ALK patients with NSCLC: a systematic review and meta-analysis.	EML4 ALK	1.75e-05	2	146	2	34783600
Pubmed	The prevalence of ALK rearrangement in pulmonary adenocarcinomas in an unselected Caucasian population from a defined catchment area: impact of smoking.	EML4 ALK	1.75e-05	2	146	2	27943404
Pubmed	Levels of free PABP are limited by newly polyadenylated mRNA in early Spisula embryogenesis.	PABPC1 PABPC3	1.75e-05	2	146	2	10954604
Pubmed	The clathrin heavy chain isoform CHC22 functions in a novel endosomal sorting step.	CLTCL1 CLTC	1.75e-05	2	146	2	20065094
Pubmed	Clinicopathological features of younger (aged ≤ 50 years) lung adenocarcinoma patients harboring the EML4-ALK fusion gene.	EML4 ALK	1.75e-05	2	146	2	29517858
Pubmed	Malignant pleural effusion cell blocks are substitutes for tissue in EML4-ALK rearrangement detection in patients with advanced non-small-cell lung cancer.	EML4 ALK	1.75e-05	2	146	2	27060609
Pubmed	The mouse gene encoding the testis-specific isoform of Poly(A) binding protein (Pabp2) is an expressed retroposon: intimations that gene expression in spermatogenic cells facilitates the creation of new genes.	PABPC1 PABPC3	1.75e-05	2	146	2	9732454
Pubmed	Whole-genome sequencing of an aggressive BRAF wild-type papillary thyroid cancer identified EML4-ALK translocation as a therapeutic target.	EML4 ALK	1.75e-05	2	146	2	24633422
Pubmed	Tumor necrosis factor-alpha suppresses the expression of steroid receptor coactivator-1 and -2: a possible mechanism contributing to changes in steroid hormone responsiveness.	NCOA2 NCOA1	1.75e-05	2	146	2	15231721
Pubmed	Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs.	EML4 ALK	1.75e-05	2	146	2	26755435
Pubmed	Effective RNA Knockdown Using CRISPR-Cas13a and Molecular Targeting of the EML4-ALK Transcript in H3122 Lung Cancer Cells.	EML4 ALK	1.75e-05	2	146	2	33255340
Pubmed	Oncogenic EML4-ALK assemblies suppress growth factor perception and modulate drug tolerance.	EML4 ALK	1.75e-05	2	146	2	39488530
Interaction	SMG7 interactions	NCOA2 IRF2BP2 SMG1 ERCC5 FMR1 WWTR1 BCOR ARID1A PABPC1 RNF43 NUP35 RNF214 FAM120A NCOA1 CNOT1	9.60e-09	319	144	15	int:SMG7
Interaction	TOP3B interactions	CLTCL1 FMR1 EP400 MYO1E KALRN PPRC1 SPTBN2 CUL9 IRF5 ICE1 ZNF395 PLXND1 REV3L COMTD1 ARID1A CIT PABPC1 RNF43 KMT2C EHBP1L1 FAM120A CELSR3 PTPRF ULK1 ESPL1 DOCK6 MYRF CNOT1 BAHCC1 KLHL17	1.38e-07	1470	144	30	int:TOP3B
Interaction	MAPRE1 interactions	SLAIN2 ERCC6 FMR1 MYO1E TROAP EML4 BAG3 PABPC1 NUP35 CEP350 KIAA1217 CLTC NAV3 TRIM36 SRRM2 CNOT1	8.68e-07	514	144	16	int:MAPRE1
Interaction	SEC16A interactions	CLTCL1 BAG3 PTPN23 WWTR1 BCOR RNF43 NUP35 RNF214 FAM120A DCP1B KIAA1217 CLTC CLINT1 ULK1	2.33e-06	426	144	14	int:SEC16A
Interaction	SH3KBP1 interactions	SLAIN2 IRF2BP2 WASL PFKFB3 PABPC1 MAP3K4 SHKBP1 ABI2 CLTC SRRM2 WIPF2 ALK	2.84e-06	315	144	12	int:SH3KBP1
Interaction	YWHAH interactions	NCOA2 SLAIN2 CDK17 MYO1E BAG3 RALGAPB SPATA18 WWTR1 ZNF395 PFKFB3 MEX3C SHKBP1 CEP350 DCP1B ABI2 KIAA1217 SIK2 NCOA1 CLINT1 SRRM2 DOCK6 SH3RF3 SAMD4A	3.46e-06	1102	144	23	int:YWHAH
Interaction	TEAD1 interactions	IRF2BP2 WWTR1 BCOR SSBP3 ARID1A CIT NUP35 KMT2C NCOA1	4.99e-06	176	144	9	int:TEAD1
Interaction	ALG13 interactions	NCOA2 FMR1 CUL9 BCOR ARID1A PABPC1 RNF43 NCOA5 FAM120A	6.84e-06	183	144	9	int:ALG13
Interaction	WWTR1 interactions	NCOA2 SLAIN2 EP400 BAG3 PTPN23 WWTR1 BCOR ARID1A NCAPH NUP35 CLTC CLINT1 CNOT1	1.09e-05	422	144	13	int:WWTR1
Interaction	NUP35 interactions	NCOA2 IRF2BP2 MYO1E WWTR1 BCOR ARID1A NUP35 NCOA5 KMT2C HOXB5 DCP1B SAP130 CNOT1	1.14e-05	424	144	13	int:NUP35
Interaction	MTA2 interactions	ERCC6 TCF19 EML4 WWTR1 BCOR ARID1A NCAPH CIT PABPC1 EHBP1L1 PABPC3 SRRM2 SAP130	1.50e-05	435	144	13	int:MTA2
Interaction	TBXT interactions	NCOA2 IRF2BP2 BCOR SSBP3 ARID1A KMT2C SAP130	2.00e-05	116	144	7	int:TBXT
Interaction	SECISBP2 interactions	FMR1 CIT PABPC1 RNF43 RNF214 TRIM36	2.02e-05	78	144	6	int:SECISBP2
Interaction	NR3C1 interactions	NCOA2 IRF2BP2 SMG1 FMR1 DHX40 MUC16 REV3L BCOR ARID1A CCDC85A SHKBP1 CEP350 PPARGC1A EHBP1L1 PITPNM3 NCOA1 TADA2A CTNND2 CNOT1 FAM149A	2.04e-05	974	144	20	int:NR3C1
Interaction	PDLIM7 interactions	TCF19 MYO1E BAG3 DNER WWTR1 CIT RNF43 ABI2 CLTC TADA2A	2.07e-05	264	144	10	int:PDLIM7
Interaction	PRRC2B interactions	FMR1 WWTR1 BCOR PABPC1 RNF43 NUP35 RNF214 FAM120A TADA2A CNOT1	2.14e-05	265	144	10	int:PRRC2B
Interaction	IQGAP1 interactions	WASL FMR1 MYO1E CORO2A SPTBN2 TRIOBP CIT PABPC1 PPARGC1A HOXB5 EAF1 CLTC SIK2 CLINT1 SRRM2	2.23e-05	591	144	15	int:IQGAP1
Interaction	SOX7 interactions	NCOA2 BCOR ARID1A KMT2C NCOA1 BAHCC1	2.69e-05	82	144	6	int:SOX7
Interaction	PXN interactions	WASL RASA1 BAG3 PTPN23 PABPC1 CEP350 DCP1B KIAA1217 CLTC CNOT1 ALK	2.90e-05	334	144	11	int:PXN
Interaction	HNF4A interactions	NCOA2 IRF2BP2 EP400 BCOR ARID1A PPARGC1A KMT2C NCOA1 TADA2A SAP130	2.93e-05	275	144	10	int:HNF4A
Interaction	MEX3B interactions	SMG1 FMR1 PABPC1 MEX3C SHKBP1 RNF214 FAM120A DCP1B CNOT1	3.19e-05	222	144	9	int:MEX3B
Interaction	EGR2 interactions	NCOA2 EP400 BCOR ARID1A KMT2C NCOA1 JPT2 BAHCC1	3.22e-05	171	144	8	int:EGR2
Interaction	TNRC6B interactions	FMR1 PTPN23 WWTR1 PABPC1 RNF43 NUP35 RNF214 DCP1B CLTC CNOT1	3.63e-05	282	144	10	int:TNRC6B
Interaction	PLXND1 interactions	PLXND1 CIT HOXB5 SEMA4A	6.77e-05	31	144	4	int:PLXND1
Interaction	SP7 interactions	NCOA2 IRF2BP2 EP400 BCOR SSBP3 ARID1A KMT2C NCOA1 SAP130 FILIP1L	6.81e-05	304	144	10	int:SP7
Interaction	SYNPO interactions	MYO1E KALRN CORO2A SPTBN2 BAG3 CIT CLTC CLINT1	7.31e-05	192	144	8	int:SYNPO
Interaction	DYNLL1 interactions	CACNB1 RELCH FMR1 DYNC2I2 EML4 WWTR1 CIT PABPC1 RNF214 KMT2C SIK2 CLINT1 SAP130	7.72e-05	510	144	13	int:DYNLL1
Interaction	YTHDF2 interactions	SMG1 FMR1 PTPN23 NCAPH PABPC1 NUP35 RNF214 FAM120A DCP1B CNOT1	8.44e-05	312	144	10	int:YTHDF2
Interaction	PAIP1 interactions	PABPC1 RNF43 NUP35 NCOA5 FAM120A SRRM2 CNOT1	8.71e-05	146	144	7	int:PAIP1
Interaction	YAP1 interactions	WASL CLTCL1 SPTBN2 BAG3 TRIOBP WWTR1 ARID1A NCAPH CIT PABPC1 KMT2C FAM120A NFE2 PABPC3 CLTC CLINT1 SRRM2 SAP130 CNOT1 JPT2	1.04e-04	1095	144	20	int:YAP1
Interaction	YWHAB interactions	SLAIN2 CDK17 BAG3 RALGAPB SPATA18 WWTR1 ZNF395 PFKFB3 RNF43 SHKBP1 CEP350 DCP1B ABI2 CLTC SIK2 SRRM2 SAP130 SH3RF3 SAMD4A	1.13e-04	1014	144	19	int:YWHAB
Interaction	CPEB4 interactions	FMR1 PABPC1 RNF43 SHKBP1 FAM120A DCP1B CNOT1	1.32e-04	156	144	7	int:CPEB4
Interaction	PAX8 interactions	NCOA2 BCOR SSBP3 ARID1A CIT KMT2C	1.47e-04	111	144	6	int:PAX8
Interaction	TMIGD2 interactions	TMIGD2 BAG3	1.51e-04	3	144	2	int:TMIGD2
Interaction	BAG2 interactions	NCOA2 IRF2BP2 EML4 BAG3 PTPN23 BCOR CIT RNF43 SHKBP1 RNF214 CLTC SIK2 ESPL1 SRRM2	1.52e-04	622	144	14	int:BAG2
Interaction	TBR1 interactions	NCOA2 BCOR SSBP3 ARID1A KMT2C BRDT	1.62e-04	113	144	6	int:TBR1
Interaction	DYRK1A interactions	ERCC5 MYO1E TROAP TRIOBP ICE1 CIT NUP35 EAF1 KIAA1217 CLTC DOCK6 CNOT1 JPT2	1.69e-04	552	144	13	int:DYRK1A
Interaction	YWHAZ interactions	TBXA2R CDK17 SYNPO2 CORO2A SPTBN2 BAG3 RALGAPB SPATA18 WWTR1 ZNF395 PFKFB3 BCOR LCP2 ARID1A MAP3K4 DCP1B ABI2 SRGAP3 CLTC SIK2 ULK1 SAMD4A	1.70e-04	1319	144	22	int:YWHAZ
Interaction	CLK1 interactions	ERCC5 BAG3 CUL9 ICE1 SSBP3 CELSR3 CTNND2 SRRM2	1.82e-04	219	144	8	int:CLK1
Interaction	NR5A2 interactions	NCOA2 CUL9 PPARGC1A NCOA1	2.06e-04	41	144	4	int:NR5A2
Interaction	YWHAG interactions	SLAIN2 CDK17 WASL SYNPO2 BAG3 RALGAPB SPATA18 WWTR1 ZNF395 PFKFB3 PABPC1 SHKBP1 CEP350 DCP1B CLTC SIK2 CLINT1 ULK1 SRRM2 SH3RF3 SAMD4A	2.15e-04	1248	144	21	int:YWHAG
Interaction	GGA3 interactions	WWTR1 RNF43 RNF214 CLTC CLINT1 ALK	2.24e-04	120	144	6	int:GGA3
Interaction	DZANK1 interactions	FMR1 KALRN CORO2A	2.26e-04	17	144	3	int:DZANK1
Interaction	DCTN1 interactions	SLAIN2 EML4 SPTBN2 BAG3 WWTR1 NCAPH CIT CEP350 KIAA1217 CLTC TRIM36 ESPL1	2.42e-04	497	144	12	int:DCTN1
Interaction	TLX1 interactions	NCOA2 IRF2BP2 BCOR SSBP3 ARID1A KMT2C SAP130	2.67e-04	175	144	7	int:TLX1
Interaction	DLGAP1 interactions	FMR1 KALRN SPTBN2 LRRTM1 CIT KIAA1217 CTNND2	3.17e-04	180	144	7	int:DLGAP1
GeneFamily	Ring finger proteins	MARCHF10 MARCHF9 RNF43 MEX3C RNF214 TRIM36 SH3RF3 RNF111	4.52e-05	275	85	8	58
GeneFamily	WD repeat domain containing\|ERCC excision repair associated	ERCC5 ERCC6	4.52e-04	7	85	2	1268
GeneFamily	Ring finger proteins\|Membrane associated ring-CH-type fingers	MARCHF10 MARCHF9	1.17e-03	11	85	2	60
Coexpression	GSE29949_MICROGLIA_VS_DC_BRAIN_UP	CCHCR1 CLTCL1 FMR1 KALRN RALGAPB LCP2 MAP3K4 ELL2 DYRK3	1.55e-06	199	143	9	M8399
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	SMG1 ARID1A CEP350 KMT2C FAM120A SRGAP3 ULK1 ESPL1	6.84e-06	180	143	8	M8239
Coexpression	GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN	NCOA2 RELCH WASL BCOR KMT2C BRDT SRRM2 FILIP1L	1.47e-05	200	143	8	M9260
Coexpression	LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP	TROAP CIT PABPC1 CELSR3 PABPC3 ESPL1	2.88e-05	108	143	6	MM1334
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	NCOA2 CACNB1 TCF19 NPAS3 WWTR1 ZNF395 LRRTM1 CCDC85A CEP350 PPARGC1A SSC5D SRGAP3 TMX4 SCN9A NCOA1 SEMA4A	4.02e-06	614	143	16	Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3	CACNB1 ERCC6 TCF19 NPAS3 WWTR1 LRRTM1 BCOR CIT CEP350 PPARGC1A SSC5D NRXN3 SRGAP3 TMX4 SCN9A NCOA1 SEMA4A CTNND2 PIGO	9.03e-06	893	143	19	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#2	CACNB1 TCF19 DYNC2I2 SPTBN2 NPAS3 WWTR1 CCDC85A CEP350 PPARGC1A SSC5D NRXN3 SRGAP3 TMX4 SCN9A NCOA1 SEMA4A	9.78e-06	659	143	16	Facebase_RNAseq_e10.5_Olfactory Pit_2500_K2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	NCOA2 IRF2BP2 SMG1 RELCH WASL SYNPO2 RASA1 KALRN DNER NPAS3 REV3L CEP350 NRXN3 CELSR3 PTPRF SLC26A7 TMX4 ALK	1.01e-05	818	143	18	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500	IRF2BP2 SMG1 RELCH SYNPO2 KALRN DNER NPAS3 REV3L CEP350 NRXN3 SLC26A7 TMX4	2.57e-05	416	143	12	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#3_top-relative-expression-ranked_200	IRF2BP2 RELCH WASL REV3L PPARGC1A	3.13e-05	54	143	5	gudmap_developingKidney_e15.5_cortic collect duct_200_k3
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#2_top-relative-expression-ranked_200	RELCH WASL REV3L PPARGC1A	6.12e-05	32	143	4	gudmap_developingKidney_e15.5_Medullary collecting duct_200_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	NCOA2 IRF2BP2 SMG1 RELCH WASL RASA1 REV3L CEP350 PTPRF TMX4 ALK	6.15e-05	385	143	11	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000	SYNPO2 ERCC6 FMR1 NPAS3 BCOR CIT PPARGC1A FNDC1 NRXN3 SLC26A7 SRGAP3 TMX4 SCN9A NCOA1 SEMA4A CTNND2 SH3RF3 PIGO	1.15e-04	986	143	18	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500	IRF2BP2 SMG1 RELCH WASL REV3L CEP350 PPARGC1A	1.20e-04	163	143	7	gudmap_developingKidney_e15.5_cortic collect duct_500_k4
ToppCell	COVID-19-Heart-Neuronal\|Heart / Disease (COVID-19 only), tissue and cell type	MYO1E KCTD1 CIT NRXN3 KIAA1217 SCN9A CTNND2 ALK	1.03e-07	173	145	8	6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-5\|TCGA-Colorectal / Sample_Type by Project: Shred V9	RELCH MYO1E SPATA18 TRIOBP KCTD1 PITPNM3 CLINT1 MYRF	1.46e-07	181	145	8	8fcc9e77fee7c248df26b6c59b10e672242e2084
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	RALGAPB R3HDML RNF43 NCOA5 FNDC1 NOD1 AEBP1 FILIP1L	1.96e-07	188	145	8	14bc73cf79c79c9f208369fd8d498e5b26e0114d
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NCOA2 RASA1 KDM4C KMT2C ELL2 SIK2 MAML2 RNF111	2.39e-07	193	145	8	779276e775cb2492e8dd36436295a536084a6415
ToppCell	3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TBXA2R SYNPO2 SSC5D HOXB5 FNDC1 AEBP1 LUZP2 FILIP1L	2.49e-07	194	145	8	91205b22650e7ecdb72bb59348ce2530b76c532c
ToppCell	3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TBXA2R SYNPO2 SSC5D HOXB5 FNDC1 AEBP1 LUZP2 FILIP1L	2.49e-07	194	145	8	6e12a7da35be4c0ecf998ef94b8989b89d74b200
ToppCell	3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TBXA2R SYNPO2 SSC5D HOXB5 FNDC1 AEBP1 LUZP2 FILIP1L	2.49e-07	194	145	8	c52f10140c66e8c0566421c3d535d5d92bf595e1
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 KALRN REV3L NRXN3 KIAA1217 SH3RF3 SAMD4A FILIP1L	2.59e-07	195	145	8	803f714d91f2d97ecbee8c15a5139fd9310f66c7
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF2BP2 REV3L KMT2C FAM120A PTPRF CLTC NCOA1 SRRM2	2.59e-07	195	145	8	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 KALRN REV3L NRXN3 KIAA1217 SH3RF3 SAMD4A FILIP1L	2.59e-07	195	145	8	4f70157d42a16ff0259bc24a62803c4df4285c44
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF2BP2 REV3L KMT2C FAM120A PTPRF CLTC NCOA1 SRRM2	2.59e-07	195	145	8	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	proximal-mesenchymal-Fibromyocyte-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TBXA2R SYNPO2 FGF23 SSC5D FNDC1 AEBP1 LUZP2 FILIP1L	3.14e-07	200	145	8	37d9f46f727a31e8e94e348e4ddd71a2125ba01a
ToppCell	proximal-3-mesenchymal-Fibromyocyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TBXA2R SYNPO2 FGF23 SSC5D FNDC1 AEBP1 LUZP2 FILIP1L	3.14e-07	200	145	8	ed6fbe61a04d29b105054f7058abe7469314b304
ToppCell	proximal-mesenchymal-Fibromyocyte\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TBXA2R SYNPO2 FGF23 SSC5D FNDC1 AEBP1 LUZP2 FILIP1L	3.14e-07	200	145	8	49658e1b530de0dad16d45a1112bdf5329bb800d
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	CACNB1 CORO2A SPATA18 WWTR1 MALRD1 KIAA2012 KLHL17	6.83e-07	152	145	7	7a1072315cce71eefe2d32149a107d5648999968
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CACNB1 CORO2A SPATA18 WWTR1 MALRD1 KIAA2012 KLHL17	7.46e-07	154	145	7	6c1e7682c43c40b58b371c58deb10b839700ebcc
ToppCell	10x5'-lymph-node_spleen-Hematopoietic_progenitors\|lymph-node_spleen / Manually curated celltypes from each tissue	TROAP RAB44 MALRD1 NFE2 SCN9A ALK BAHCC1	1.69e-06	174	145	7	029394e107bf7ad58056d2216070aa2e964fff12
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	KALRN PFKFB3 REV3L LUZP2 SH3RF3 SAMD4A FILIP1L	2.28e-06	182	145	7	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	AT1-AT2_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	CIT CCDC85A PPARGC1A FNDC1 PTPRF CTNND2 MYRF	2.36e-06	183	145	7	6821dca076318115d360ff426eb1218cfe104063
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN WWTR1 PLXND1 NOD1 NAV3 DOCK6 SH3RF3	2.73e-06	187	145	7	35c382c0aabd46906113e5db30ea24bb8e658899
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CDK17 SYNPO2 KALRN AEBP1 MAML2 SEMA4A SAMD4A	3.03e-06	190	145	7	1121eb607a984c59fbffe7220837fc178745aa55
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CDK17 SYNPO2 KALRN AEBP1 MAML2 SEMA4A SAMD4A	3.03e-06	190	145	7	048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RAB17 CCDC85A PPARGC1A PTPRF CTNND2 MYRF SAMD4A	3.03e-06	190	145	7	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TAGAP CEP350 CLTC TMX4 NAV3 SRRM2 FILIP1L	3.36e-06	193	145	7	06b65110db974f4ef90d3511ff34428976a52c9c
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TAGAP CEP350 CLTC TMX4 NAV3 SRRM2 FILIP1L	3.36e-06	193	145	7	9c16032bc03df8760ae199e8f19fdafa4c3f1827
ToppCell	facs-Brain_Myeloid-Hippocampus-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TAGAP CEP350 CLTC TMX4 NAV3 SRRM2 FILIP1L	3.36e-06	193	145	7	a4f91bca5eaa985982d33a528f7566ffde154d47
ToppCell	COVID-19-Endothelial_cells-Inflamed_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	CDK17 KALRN WWTR1 CCDC85A KIAA1217 DOCK6 SH3RF3	3.36e-06	193	145	7	979ebefa527f86bebeea5d94e626ee6c1cc7d53b
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TAGAP CEP350 CLTC TMX4 NAV3 SRRM2 FILIP1L	3.36e-06	193	145	7	b39d7feaac4ff8f7409cd3d15e8f3c6391367275
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SYNPO2 SSC5D HOXB5 FNDC1 AEBP1 LUZP2 FILIP1L	3.47e-06	194	145	7	8fae8061b350336299aa81f378e07deadbd55123
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SYNPO2 SSC5D HOXB5 FNDC1 AEBP1 LUZP2 FILIP1L	3.47e-06	194	145	7	4d7d24390fdb379f943ddcc70a63f23955e10163
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	SYNPO2 LRRTM1 FGF23 SSC5D FNDC1 LUZP2 FILIP1L	3.59e-06	195	145	7	4dba732c8d8ecf0ed9ece1814dc4060402199ed9
ToppCell	Fibroblast-B_(Myofibroblast)\|World / shred on cell class and cell subclass (v4)	SYNPO2 SSC5D HOXB5 FNDC1 NRXN3 SAMD4A FILIP1L	3.59e-06	195	145	7	a8d6416518f226e1ec2d6bdc9d4b90cef5cb1365
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 REV3L NRXN3 KIAA1217 SH3RF3 SAMD4A FILIP1L	3.72e-06	196	145	7	2b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCell	Healthy_Control-Lymphoid-T-Proliferating_T\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	TCF19 DYNC2I2 TROAP NCAPH CIT ESPL1 GASK1A	3.84e-06	197	145	7	3ce3dcbbe0edeb5a6fb5596dd6c2b4d6c1d5159d
ToppCell	P03-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SYNPO2 SSC5D HOXB5 FNDC1 NRXN3 SAMD4A FILIP1L	3.84e-06	197	145	7	2cec938caf6ffd031cea37277071487e59b2c71c
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SYNPO2 SSC5D HOXB5 FNDC1 AEBP1 LUZP2 FILIP1L	3.84e-06	197	145	7	16758f181ef07c60aee63072e1da9572c5c85414
ToppCell	P03-Mesenchymal-myocytic_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SYNPO2 SSC5D HOXB5 FNDC1 NRXN3 SAMD4A FILIP1L	3.84e-06	197	145	7	079db904a08743b3c555cb7b3f5fb5c978dde25a
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SYNPO2 SSC5D HOXB5 FNDC1 NRXN3 SAMD4A FILIP1L	3.84e-06	197	145	7	9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0
ToppCell	distal-3-mesenchymal-Fibromyocyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SYNPO2 FGF23 SSC5D FNDC1 AEBP1 LUZP2 FILIP1L	3.97e-06	198	145	7	dc93886439a378a0c71e99acb8081bfb6b6d467b
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	SMG1 PFKFB3 LCP2 KMT2C EAF1 OTOF SRRM2	3.97e-06	198	145	7	61ceb2245b6cb58e308b999a61d218c89dbc615e
ToppCell	medial-2-mesenchymal-Myofibroblast\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SYNPO2 NPAS3 SSC5D FNDC1 AEBP1 LUZP2 GASK1A	4.11e-06	199	145	7	95aae608fa35a9c82b12c6f18937ce636750ca44
ToppCell	medial-mesenchymal-Myofibroblast\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SYNPO2 NPAS3 SSC5D FNDC1 AEBP1 LUZP2 GASK1A	4.11e-06	199	145	7	e25acdb5809aaff631cb06dbe4c7e59549a0bdb9
ToppCell	medial-mesenchymal-Myofibroblast-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SYNPO2 NPAS3 SSC5D FNDC1 AEBP1 LUZP2 GASK1A	4.11e-06	199	145	7	9ebf4822ff9fa08574edec5dbf4f2a1488f34b1d
ToppCell	(24)_B_cell_cycling\|World / shred on Cell_type and subtype	CLTCL1 TCF19 DYNC2I2 MYO1E TROAP NCAPH CIT	4.53e-06	202	145	7	a7c9b6b173701348ba35fbb975e0bdd3c1f1d5fe
ToppCell	droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l33\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KCTD1 REV3L RAB44 EAF1 SIK2 ARMCX6	5.62e-06	136	145	6	a43b3db1754c619d328a26a2ba6af4756629a723
ToppCell	COVID-19-kidney-Technical/muscle_(EC)\|kidney / Disease (COVID-19 only), tissue and cell type	MUC16 NRXN3 MALRD1 LUZP2 CTNND2 KIAA2012	6.38e-06	139	145	6	64c35411bbe67acb5010dadc4b0b1be0f8b17737
ToppCell	343B-Myeloid-Macrophage-SPP1+_Macrophage_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	CACNB1 BAG3 SPATA18 SSC5D NFE2 DYRK3	1.15e-05	154	145	6	874b1220337276489a89fcc9a39bc81ba6b68baf
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TBXA2R KALRN TROAP PLXND1 NAV3 SH3RF3	1.19e-05	155	145	6	59035d792c26d870a8b097939e97fa47859ba68c
ToppCell	PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TCF19 CORO2A EHBP1L1 VENTX SRGAP3 SEMA4A	1.23e-05	156	145	6	8349604bd801e20d33770f7d8243598c3756302b
ToppCell	droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MARCHF10 PPRC1 PFKFB3 SPATA1 MAML2 RASGRP2	1.33e-05	158	145	6	1d78578dc1f8ba43dacdccae1082c0b9d749f64d
ToppCell	facs-Brain_Myeloid-Cerebellum-24m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLXND1 OTOF NFE2 KCTD14 SEMA4A RASGRP2	1.42e-05	160	145	6	1f7acdc8b08152d5817fc53bbf47b4a22d9c91b5
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MARCHF10 SPTBN2 PFKFB3 SUSD1 SLC26A7 SRGAP3	1.47e-05	161	145	6	176a4a72bb4892932da3c834d1fea5e211847f92
ToppCell	PND07-Immune-Immune_Myeloid-DC-cDC1\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CORO2A IRF5 SRGAP3 KCTD14 CLINT1 SEMA4A	1.64e-05	164	145	6	662f74ad2656c0af158dbf9eb81d5bf70f54e529
ToppCell	10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor\|lymph-node_spleen / Manually curated celltypes from each tissue	RAB44 MALRD1 NFE2 SCN9A ALK BAHCC1	1.69e-05	165	145	6	7b992843bd8ef92a7a76b1d681fa84efde6f5bdd
ToppCell	facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RAB17 RNF43 PTPRF MYRF SH3RF3 SAMD4A	1.81e-05	167	145	6	bebc2493a2ee41920b21c2b774a1c5a9619315c4
ToppCell	facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RAB17 RNF43 PTPRF MYRF SH3RF3 SAMD4A	1.81e-05	167	145	6	9f2661729a2d58e17a9203a563d538c08a3dbbbc
ToppCell	Frontal_cortex-Neuronal-Inhibitory\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	DNER NPAS3 FNDC1 NRXN3 SCN9A ALK	1.94e-05	169	145	6	78eb70dd916724e476eabccf18fb7fcec4210308
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CORO2A PLXND1 BCOR NCOA5 SIK2 MAML2	2.14e-05	172	145	6	a9e13aa36087170dadca421ba9de588e5a1cf715
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Proliferating_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TROAP CORO2A NCAPH SRGAP3 KCTD14 CTNND2	2.21e-05	173	145	6	6c9ecf77d2fb0f89100fdd7e4e88f85598278bc7
ToppCell	E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RAB44 SSC4D SUSD1 NFE2 SEMA4A KIAA2012	2.21e-05	173	145	6	2cba41c3d9d3076f703115d19729073a3ac3feb6
ToppCell	E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RAB44 SSC4D SUSD1 NFE2 SEMA4A KIAA2012	2.21e-05	173	145	6	11d69a4ab4a87b8820cd3bd204de8c4124450a90
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAB17 KCTD1 PABPC1 RAB44 FNDC1 NFE2	2.29e-05	174	145	6	a9f34d1237f335d27c5560ff514368f4709f9144
ToppCell	facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TCF19 CORO2A IRF5 OTOF KCTD14 FAM149A	2.29e-05	174	145	6	6688424fc4e40c3c4a89669a2bc79369a726f1e6
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SYNPO2 SSC5D AEBP1 LUZP2 MAML2 FILIP1L	2.36e-05	175	145	6	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TCF19 IRF5 OTOF KCTD14 CLINT1 TRIM36	2.44e-05	176	145	6	7b5e50eb144bf43ca0cf354a466eb58b976a79f1
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-DN3_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAB17 KCTD1 PABPC1 RAB44 FNDC1 NFE2	2.44e-05	176	145	6	d43d9e86c4d4fa1e88fbf2b899ac7143717aac90
ToppCell	droplet-Liver-Npc-18m-Lymphocytic-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCHCR1 ERCC6 DYNC2I2 KCTD1 NFE2 BAHCC1	2.60e-05	178	145	6	09d2687e0d79f12e90af35fc1c0453d249cf2d19
ToppCell	facs-Lung-EPCAM-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF19 IRF5 OTOF KCTD14 SEMA4A FAM149A	2.60e-05	178	145	6	8c5e9fab7b55a654ccaabf2c4d02397399d94616
ToppCell	COVID-19-kidney-PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CDK17 KALRN WWTR1 KIAA1217 DOCK6 SH3RF3	2.77e-05	180	145	6	493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SYNPO2 SSC5D HOXB5 FNDC1 AEBP1 LUZP2	2.85e-05	181	145	6	9c157de9d3403e092c907599f2a2c16db5b21131
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SYNPO2 SSC5D HOXB5 FNDC1 AEBP1 LUZP2	2.85e-05	181	145	6	eea943fdcbef0bbaa8578f3296923e874893b405
ToppCell	mild_COVID-19_(asymptomatic)-T/NK_proliferative\|World / disease group, cell group and cell class (v2)	TCF19 TROAP NCAPH CIT FGF23 ESPL1	2.94e-05	182	145	6	9adf90bb2808f234d53b89ca0ae07380478204ad
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMG1 EML4 IRF5 CEP350 CLINT1 FILIP1L	2.94e-05	182	145	6	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SYNPO2 SSC5D HOXB5 FNDC1 AEBP1 LUZP2	3.04e-05	183	145	6	bc7dd6a40ec9c773d005c1a46f305d40cdd0a326
ToppCell	367C-Lymphocytic-NK_cells-Proliferating_NK_cell\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	DYNC2I2 TROAP PPRC1 CUL9 NCAPH CIT	3.04e-05	183	145	6	a716b446c2bf5aa294b8f580aa845098fae76354
ToppCell	mild_COVID-19_(asymptomatic)-T/NK_proliferative\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	TCF19 DYNC2I2 TROAP NCAPH CIT ESPL1	3.04e-05	183	145	6	df8568751205313d149939ea2683097e3652a60b
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CCDC85A PPARGC1A PTPRF CTNND2 MYRF SAMD4A	3.13e-05	184	145	6	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CCDC85A PPARGC1A PTPRF CTNND2 MYRF SAMD4A	3.13e-05	184	145	6	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	(7)_MNP-(7)_DC_plasmacytoid\|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1)	IRF2BP2 MARCHF9 TMIGD2 SUSD1 AEBP1 SCN9A	3.23e-05	185	145	6	9f67f652488e17075a372e2a2e1100f6d0af6d7d
ToppCell	COVID-19-kidney-FLT1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CDK17 KALRN WWTR1 ELL2 DOCK6 SH3RF3	3.23e-05	185	145	6	673308ca0514a4d3629d61fe91e9d8fb31b72166
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMG1 EML4 IRF5 CEP350 CLINT1 FILIP1L	3.23e-05	185	145	6	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CDK17 SYNPO2 ELL2 SH3RF3 SAMD4A FILIP1L	3.23e-05	185	145	6	e58a009aaf342be019a909747b1895d5987d4daf
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_4\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	WASL BAG3 CUL9 IRF5 DCP1B TADA2A	3.33e-05	186	145	6	bca5215d406f1785bf3a420201d5686071fcaca5
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DNER NPAS3 LCP2 OTOF KIAA1217 RASGRP2	3.43e-05	187	145	6	85f1678338a47d91e296f0620d4887f057eb7e70
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MARCHF10 SPTBN2 PFKFB3 SUSD1 SLC26A7 SRGAP3	3.43e-05	187	145	6	2d17408b3b5f09d135084fd7ccce98e6b5ca632b
ToppCell	367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	TCF19 DYNC2I2 TROAP NCAPH CIT ESPL1	3.53e-05	188	145	6	f5102e8d95506c25c675094b86162a6a50087b64
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1E SPTBN2 NPAS3 PFKFB3 SUSD1 SRGAP3	3.64e-05	189	145	6	fc88c51ace7d883c01617f3f9b5fab70cc91cc09
ToppCell	Mesenchymal-airway_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	SYNPO2 SSC5D FNDC1 AEBP1 LUZP2 FILIP1L	3.75e-05	190	145	6	645e56b02edc3702c7db917b8ecd5eed0decaf71
ToppCell	PCW_05-06-Hematologic_ErythroMegGranulo-Hem_Granulocytic\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	TAGAP IRF5 LCP2 RAB44 NFE2 RASGRP2	3.75e-05	190	145	6	8e254fc77dd1d2d2a4ce0700af3c37829ca089bf
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	KALRN EML4 REV3L NOD1 SH3RF3 SAMD4A	3.86e-05	191	145	6	08720998aa55131d7377c4c67c4c935865bd7d79
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	CDK17 EML4 ELL2 SRRM2 CNOT1 FILIP1L	3.86e-05	191	145	6	1ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CDK17 KALRN WWTR1 KIAA1217 DOCK6 SH3RF3	3.86e-05	191	145	6	2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	TROAP CORO2A CIT NRXN3 CTNND2 ESPL1	3.97e-05	192	145	6	25378b5e4b0cea8415ff125783511fc25a56fc00
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPAS3 PPARGC1A LUZP2 SEMA4A CTNND2 GASK1A	3.97e-05	192	145	6	261211a86e6f63b09c2ddce1d2d9257d311f1770
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	CDK17 MYO1E PPRC1 EML4 SH3RF3 SAMD4A	3.97e-05	192	145	6	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	Control-Lymphoid-Proliferating_CD4_T_cells\|Control / Condition, Lineage and Cell class	TCF19 DYNC2I2 TROAP NCAPH CIT ESPL1	4.09e-05	193	145	6	33d409d6ed1c606337248587ad997ac5f67f081d
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMG1 RELCH KDM4C EML4 MAP3K4 ALK	4.09e-05	193	145	6	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	COVID-19-kidney-FLT1+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	CDK17 KALRN WWTR1 ELL2 DOCK6 SH3RF3	4.09e-05	193	145	6	479abb1cd2eb978b8a4fdb900069a6329fc8cade
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TCF19 DYNC2I2 TROAP NCAPH CIT ESPL1	4.21e-05	194	145	6	f39a471293ecc5c5967b00e772b8f48ebc9affbe
ToppCell	Control-Lymphoid_T/NK-T/NK_proliferative\|Control / Disease group, lineage and cell class	TCF19 DYNC2I2 TROAP NCAPH CIT ESPL1	4.21e-05	194	145	6	9bbb124001fba7450f4639f47f9b720a483e7242
Drug	Acetohexamide [968-81-0]; Up 200; 12.4uM; PC3; HT_HG-U133A	CDK17 CHCHD7 EML4 PLXND1 ARID1A RNF43 NOD1 TADA2A DYRK3	3.40e-06	192	142	9	1829_UP
Drug	(S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; PC3; HT_HG-U133A	NPAS3 CUL9 PLXND1 NOD1 SRGAP3 KCTD14 CTNND2 ALK SAMD4A	4.20e-06	197	142	9	6725_UP
Drug	Suramin sodium salt; Up 200; 10uM; MCF7; HT_HG-U133A	TBXA2R RNF43 HOXB5 EHBP1L1 CELSR3 NCOA1 FILIP1L DYRK3 BAHCC1	4.56e-06	199	142	9	7496_UP
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 PPRC1 ARID1A MEX3C NOD1 TADA2A SAMD4A RASGRP2	1.28e-05	172	142	8	5903_DN
Disease	Mobius Syndrome	PLXND1 REV3L	2.27e-05	2	141	2	C0221060
Disease	Mobius II syndrome	PLXND1 REV3L	2.27e-05	2	141	2	C0853240
Disease	stomach cancer (is_implicated_in)	ERCC5 ERCC6 BCOR ARID1A KMT2C	2.51e-05	72	141	5	DOID:10534 (is_implicated_in)
Disease	citrate measurement	CLTCL1 PFKFB3 CNOT1 ALK SAMD4A	3.94e-05	79	141	5	EFO_0010114
Disease	Carcinoma, Transitional Cell	ARID1A PABPC1 KMT2C ESPL1	4.41e-05	41	141	4	C0007138
Disease	mean corpuscular hemoglobin concentration	IRF2BP2 WASL EP400 KALRN PABPC1 RNF43 EHBP1L1 ELL2 BRDT SUSD1 NFE2 KIAA1217 KIAA2012 MYRF PIGO DYRK3	8.05e-05	1105	141	16	EFO_0004528
Disease	level of Phosphatidylethanolamine (18:0_20:4) in blood serum	MYO1E MYRF RNF111	9.79e-05	19	141	3	OBA_2045140
Disease	Cerebrooculofacioskeletal Syndrome 1	ERCC5 ERCC6	1.35e-04	4	141	2	C0220722
Disease	Intrahepatic Cholangiocarcinoma	ARID1A RNF43 KMT2C	2.01e-04	24	141	3	C0345905
Disease	Extrahepatic Cholangiocarcinoma	ARID1A RNF43 KMT2C	2.01e-04	24	141	3	C3805278
Disease	stomach carcinoma (is_marker_for)	KDM4C RNF43 KMT2C	2.01e-04	24	141	3	DOID:5517 (is_marker_for)
Disease	kidney failure (implicated_via_orthology)	TBXA2R PPARGC1A	2.25e-04	5	141	2	DOID:1074 (implicated_via_orthology)
Disease	Klatskin's tumor (is_implicated_in)	ARID1A KMT2C	2.25e-04	5	141	2	DOID:4927 (is_implicated_in)
Disease	Cholangiocarcinoma	ARID1A RNF43 KMT2C	2.56e-04	26	141	3	C0206698
Disease	cortical thickness	NCOA2 IRF2BP2 CHCHD7 SPTBN2 TRIOBP CUL9 PLXND1 SSBP3 RAB44 MALRD1 PTPRF SRGAP3 NAV3 TRIM36 SH3RF3	2.94e-04	1113	141	15	EFO_0004840
Disease	interleukin 5 measurement	NRXN3 SH3RF3 SAMD4A	3.21e-04	28	141	3	EFO_0008185
Disease	larynx cancer (is_implicated_in)	ERCC5 ERCC6	3.36e-04	6	141	2	DOID:2596 (is_implicated_in)
Disease	Inflammatory Myofibroblastic Tumor	CLTC ALK	3.36e-04	6	141	2	C0334121
Disease	Cockayne syndrome (implicated_via_orthology)	ERCC5 ERCC6	3.36e-04	6	141	2	DOID:2962 (implicated_via_orthology)
Disease	Bilateral Wilms Tumor	BCOR ARID1A MAP3K4	3.56e-04	29	141	3	C2930471
Disease	Congenital Pain Insensitivity	CLTCL1 SCN9A	4.69e-04	7	141	2	C0002768
Disease	lung non-small cell carcinoma (is_implicated_in)	NCOA2 ERCC5 ERCC6 ARID1A KMT2C	5.59e-04	139	141	5	DOID:3908 (is_implicated_in)
Disease	Embryonal Rhabdomyosarcoma	BCOR ARID1A	6.23e-04	8	141	2	C0206656
Disease	Nephroblastoma	BCOR ARID1A MAP3K4	6.79e-04	36	141	3	C0027708
Disease	heart disease (implicated_via_orthology)	WWTR1 PPARGC1A CNOT1	7.97e-04	38	141	3	DOID:114 (implicated_via_orthology)
Disease	Liver Diseases, Parasitic	RNF43 KMT2C	7.98e-04	9	141	2	C0023897
Disease	comparative body size at age 10, self-reported	CHCHD7 KDM4C NPAS3 SSBP3 HOXB5 NRXN3 FAM120A ALK	9.63e-04	420	141	8	EFO_0009819
Disease	Microphthalmos	ERCC6 MYRF	1.21e-03	11	141	2	C0026010
Disease	Basal cell carcinoma	ERCC5 RASA1	1.21e-03	11	141	2	C0007117
Disease	Adenoid Cystic Carcinoma	BCOR ARID1A KMT2C ESPL1	1.37e-03	100	141	4	C0010606
Disease	spontaneous preterm birth	KALRN NPAS3 PFKFB3 KIAA1217	1.42e-03	101	141	4	EFO_0006917
Disease	triacylglycerol 58:12 measurement	DNER NRXN3	1.45e-03	12	141	2	EFO_0010439
Disease	stomach carcinoma (is_implicated_in)	BCOR RNF43	1.45e-03	12	141	2	DOID:5517 (is_implicated_in)
Disease	level of Phosphatidylinositol (18:1_18:1) in blood serum	DOCK6 MYRF	1.71e-03	13	141	2	OBA_2045159
Disease	level of Phosphatidylethanolamine (18:1_18:1) in blood serum	MYO1E RNF111	1.99e-03	14	141	2	OBA_2045142
Disease	Colorectal Carcinoma	CACNB1 RELCH ERCC6 KALRN SPTBN2 ARID1A RNF43 KMT2C CTNND2 PIGO	2.07e-03	702	141	10	C0009402
Disease	plasminogen activator inhibitor 1 measurement	KDM4C MAP3K4 LUZP2	2.22e-03	54	141	3	EFO_0004792
Disease	amyotrophic lateral sclerosis, age at onset	NRXN3 PTPRF	2.29e-03	15	141	2	EFO_0004847, MONDO_0004976
Disease	Nasal Cavity Polyp	NCOA1 LUZP2 MYRF	2.34e-03	55	141	3	EFO_1000391
Disease	hip bone mineral density, hip bone size	TRIOBP KIAA1217 TADA2A	2.46e-03	56	141	3	EFO_0004844, EFO_0007702
Disease	health study participation	IRF2BP2 FAM120A CELSR3 PTPRF SIK2	2.51e-03	195	141	5	EFO_0010130
Disease	T-Cell Lymphoma	KDM4C ARID1A	2.60e-03	16	141	2	C0079772
Disease	level of Phosphatidylethanolamine (16:0_20:4) in blood serum	MYO1E RNF111	2.60e-03	16	141	2	OBA_2045137
Disease	PR interval	KALRN EML4 CUL9 SSBP3 PPARGC1A CTNND2 WIPF2 CNOT1	2.69e-03	495	141	8	EFO_0004462
Disease	Endometrial Neoplasms	ARID1A RNF43 MAP3K4	2.72e-03	58	141	3	C0014170
Disease	pulse pressure measurement	SLAIN2 MYO1E TRIOBP IRF5 PPARGC1A FNDC1 MALRD1 SLC26A7 ABI2 KIAA1217 PITPNM3 CTNND2 CNOT1 SAMD4A FILIP1L	2.77e-03	1392	141	15	EFO_0005763
Disease	colorectal health	EML4 NRXN3 PITPNM3 LUZP2 ESPL1	2.86e-03	201	141	5	EFO_0008460
Disease	plasma beta-amyloid 1-40 measurement	NPAS3 RNF214	2.94e-03	17	141	2	EFO_0005659
Disease	triacylglycerol 56:9 measurement	BCOR CCDC85A	2.94e-03	17	141	2	EFO_0010436
Disease	response to cranial radiation therapy, short-term memory	NRXN3 MALRD1 DBX1	3.00e-03	60	141	3	EFO_0004335, EFO_0010950
Disease	urate measurement, bone density	DNER NPAS3 MEX3C PPARGC1A FNDC1 LUZP2 MAML2 CTNND2 SH3RF3	3.00e-03	619	141	9	EFO_0003923, EFO_0004531
Disease	Adenocarcinoma of lung (disorder)	RASA1 EML4 AURKC ULK1 ALK	3.17e-03	206	141	5	C0152013
Disease	level of Phosphatidylinositol (18:0_18:1) in blood serum	DOCK6 MYRF	3.30e-03	18	141	2	OBA_2045155
Disease	tea consumption measurement	KDM4C CUL9 NRXN3 SAMD4A	3.47e-03	129	141	4	EFO_0010091
Disease	Schizophrenia	FMR1 SPTBN2 NPAS3 LRRTM1 R3HDML PPARGC1A NRXN3 SLC26A7 SRGAP3 CTNND2 ALK	3.51e-03	883	141	11	C0036341
Disease	cumulative dose response to bevacizumab	PFKFB3 MAML2	3.68e-03	19	141	2	EFO_0005944
Disease	facial asymmetry measurement	NPAS3 NRXN3	3.68e-03	19	141	2	EFO_0009751
Disease	intrahepatic cholangiocarcinoma (is_marker_for)	ARID1A RNF43	3.68e-03	19	141	2	DOID:4928 (is_marker_for)
Disease	hip bone size	TRIOBP KIAA1217 TADA2A	3.76e-03	65	141	3	EFO_0004844
Disease	Bladder Neoplasm	ARID1A PABPC1 KMT2C ESPL1	4.64e-03	140	141	4	C0005695
Disease	Malignant neoplasm of urinary bladder	ARID1A PABPC1 KMT2C ESPL1	4.76e-03	141	141	4	C0005684

Protein segments in the cluster

Peptide	Gene	Start	Entry
SLPQMVASTRLPVDP	EP400	676	Q96L91
TANPCSGPRLTPRMQ	BAHCC1	1396	Q9P281
MPSVTQRLRDPDINP	CHCHD7	1	Q9BUK0
TAQQPSSPAMRRLTV	AURKC	26	Q9UQB9
TVPERKRSTPMNPAN	ELL2	176	O00472
SSTPPNPLLNRTMAT	CACNB1	416	Q02641
MSLPSRQTAIIVNPP	BRDT	1	Q58F21
DPSRPMTPQQRRLQQ	AEBP1	1006	Q8IUX7
QETTQSRPMPPEARR	BCOR	1441	Q6W2J9
PNNRSASAPASPREM	CTNND2	1066	Q9UQB3
QPSAMSLLAPPSSRR	CIT	1326	O14578
ARMEQQPTRPPQTSQ	EAF1	121	Q96JC9
SMARNTSPTPDPTVR	ARMCX6	161	Q7L4S7
SPTRNMAPSQQSPVR	ABI2	216	Q9NYB9
MAQAHRTPQPRAAPS	RAB17	1	Q9H0T7
NPRMFNIISDSPSPI	RASA1	911	P20936
PTMAEQEAQPRPSLT	RAB44	766	Q7Z6P3
STRPMGPQAAPLTIR	PTPN23	1056	Q9H3S7
PPFSTMRPASSQVPR	PABPC1	461	P11940
SQIPPLPGMSRSNSV	ARID1A	1171	O14497
LPASRLPVAAVQPMT	FBXW10B	716	O95170
TFTVQQPPPSRRRKM	ERCC6	561	P0DP91
RFPRPMSPLQDVSTI	RELCH	786	Q9P260
NMLATERVSLSPSPP	MUC16	3276	Q8WXI7
SPQLRRSVSVDMPRP	KMT2C	2511	Q8NEZ4
VNLSSPSNMLPVRPQ	CLINT1	526	Q14677
PSNMLPVRPQTNALI	CLINT1	531	Q14677
MVTSLRPPVQANPDL	RASGRP2	346	Q7LDG7
MASPLVQTSRSRFPP	FAM149A	646	A5PLN7
TQLPNTTFRPMPNLR	LRRTM1	126	Q86UE6
CNQTRMLTSTPAPPR	ERVFC1-1	341	P60608
QIGLNTMSRSRSPSP	SPATA18	516	Q8TC71
PSSRPNRMASNIFGP	JPT2	36	Q9H910
LTRMPSSVPLRAPAQ	DYNC2I2	371	Q96EX3
MQNPVITAISPRRSP	PLXND1	1066	Q9Y4D7
MSRPLITRSPASPLN	KCTD1	1	Q719H9
MNTAPSRPSPTRRDP	NCOA5	1	Q9HCD5
NGRTIPNLTSRPTPM	NAV3	726	Q8IVL0
LMRRNSVTPLASPEP	PFKFB3	456	Q16875
RSVPTASMSPPRQGA	DBX1	56	A6NMT0
MRSQPARLPQASPRP	KALRN	2251	O60229
PLITSPMFRNVPTAN	NRXN3	1531	Q9Y4C0
PEMRSSRQPAQDTAP	EHBP1L1	286	Q8N3D4
MQPSSLVQRNTRSPV	NOD1	436	Q9Y239
SRPPARSPMTLVKQQ	KDM4C	576	Q9H3R0
NSPPSLPNMRVPRRA	KIAA2012	566	Q0VF49
LQINSPPFDQPMSRR	CDK17	161	Q00537
RSDTPAMLNPANVPT	FAM120A	696	Q9NZB2
MNQSIPVAPTPPRRV	IRF5	1	Q13568
PTSGATSRPPAAQRM	MARCHF9	291	Q86YJ5
TSRPPAAQRMRTLLP	MARCHF9	296	Q86YJ5
MASVRAVPNQRAPPS	PABPC3	386	Q9H361
SPSLARAQPEPMATS	HOXB5	151	P09067
VSPPKSLFSQRPQRM	PPARGC1A	551	Q9UBK2
QQSQRSTPRPSLPME	MAML2	346	Q8IZL2
PQQPMRAARISSPVI	MALRD1	1361	Q5VYJ5
SPQRIPATAAPSLLM	DCP1B	511	Q8IZD4
SAMAVTRFPPQRPSA	GASK1A	26	Q9UFP1
SMPSLQALPVTRLPS	ESPL1	1906	Q14674
EIMPPNSLPSNNSRV	FMR1	331	Q06787
MPQNENPQSRPEARS	ICE1	1336	Q9Y2F5
MQPRSERPAGRTQSP	KLHL17	1	Q6TDP4
MAPTPPGLRNSLNRA	DOCK6	2026	Q96HP0
MQAVASPVRPASPSA	FILIP1L	1071	Q4L180
SVPRRMTPGRAPQQQ	FNDC1	991	Q4ZHG4
NVLKPRARMTPAPAS	FGF23	191	Q9GZV9
MTQPVPRLSVPAALA	COMTD1	1	Q86VU5
AERPIFNSMAPASPR	CORO2A	411	Q92828
PAASRTTTENMAPIP	CEP350	1301	Q5VT06
FQARPLSTLPRMAPT	CCHCR1	16	Q8TD31
MLPQASQNRRQPPTR	CCDC85A	436	Q96PX6
SNPTRMLLPPRNIAS	LUZP2	231	Q86TE4
PNQERRNLVPSSQPM	MARCHF10	196	Q8NA82
RNLVPSSQPMTENAP	MARCHF10	201	Q8NA82
RPGVPTMSLLNSSRP	ITIH6	961	Q6UXX5
RNLSEQGMSPPRPTR	CUL9	321	Q8IWT3
QPSPRAVIPMSCITN	EML4	71	Q9HC35
ARLPQNPVMNSPVVS	CELSR3	2431	Q9NYQ7
PQRSQSPLRGMPETT	BAG3	131	O95817
RPQQPMTHRETAPVS	BAG3	301	O95817
ESMAPRQLQPVPATQ	DNER	146	Q8NFT8
SMTTDQQRRIFLPPP	DHX40	321	Q8IX18
NSPPSPSSMNQRRLG	IRF2BP2	456	Q7Z5L9
DMNTRTPPEPSAKQR	PPRC1	1386	Q5VV67
PPPPRRLNMTTEQFT	DYRK3	56	O43781
PAPAQPESTAMRLLS	R3HDML	31	Q9H3Y0
DLASVSSTPPMRPQV	OTOF	681	Q9HC10
SSTPPMRPQVTDRNY	OTOF	686	Q9HC10
QAPSSPPRRVQARML	PTPRF	411	P10586
MSPCPPQQSRNRVIQ	NFE2	1	Q16621
TPLTSRRQPNISVMQ	NUP35	106	Q8NFH5
QPGSTPRISTMRPLA	NUP35	276	Q8NFH5
SVPMPIARPARQTSR	MAP3K4	201	Q9Y6R4
SNQSSPRLRLPSPSM	TRIM36	76	Q9NQ86
GTQPLLPNSMDPTRQ	SSBP3	176	Q9BWW4
PSAPSQSRMTSERAP	SRRM2	2411	Q9UQ35
VSPQPMISRLQQPRL	SLAIN2	376	Q9P270
SSPSRQPQVPMATAA	TAGAP	326	Q8N103
IPMASNSGRRSAPPL	TADA2A	351	O75478
MSIPRVNPSVNPSIS	NCOA1	381	Q15788
LPPSNSNMVSTRINR	NCOA1	406	Q15788
LITSPMFRNVPTANP	NRXN3	526	Q9HDB5
PVAVARQTMLAPSPS	PRR20G	161	P0DPQ3
DLLINRPQAMSVTPP	SMG1	3206	Q96Q15
RPQAMSVTPPPRSAI	SMG1	3211	Q96Q15
DATPPSPRTLLAMQA	ERCC5	336	P28715
LSSNPVPPSRARMIS	MEX3C	426	Q5U5Q3
PMSRSLRPQSRPQII	SEMA4A	551	Q9H3S1
DPQRVDMQPSVTSRP	RNF43	516	Q68DV7
TGLSQPVLRQPNMSP	SATL1	176	Q86VE3
NISQASRSPPMLPVN	SCN9A	601	Q15858
PHTMQPDRASPSRQA	KIAA1217	496	Q5T5P2
APVRRSNTMPPNLGN	SHKBP1	156	Q8TBC3
ANQPSPRMTSPFISL	SIK2	541	Q9H0K1
PFISLRPTNPAMQAL	SIK2	551	Q9H0K1
MAPTKPSFQQDPSRR	NPAS3	1	Q8IXF0
VGRMTSQTPLPQSPR	KCTD14	11	Q9BQ13
NSTPREAASRPPSTM	SSC5D	421	A1L4H1
QSSPAPSRQVTMLPA	TRIOBP	1346	Q9H2D6
PIQTLVNMSLNPSRP	SPATA1	16	Q5VX52
TRPRPSQPSSLAMLD	ALK	1211	Q9UM73
PIRRPISADSAIMNP	CLTC	61	Q00610
PIRRPISAESAIMNP	CLTCL1	61	P53675
RSLPPVMAQNLSIPL	NCAPH	696	Q15003
IPPTLAMNPQAQALR	CNOT1	1626	A5YKK6
IRNPAASIPMRPSSQ	NCOA2	981	Q15596
ASIPMRPSSQPGQRQ	NCOA2	986	Q15596
SAQMPAPRTQPDLIL	SHANK2-AS3	6	Q9BTD1
MGTTPSAPPQRNRRK	TCF19	211	Q9Y242
RALFPAPLAQISTPM	RNF214	621	Q8ND24
ALPPEQSRVQPMTAS	TMX4	31	Q9H1E5
VSMVRVSPRPSPTQQ	TMIGD2	256	Q96BF3
VNQPATPFSPTRNMT	SYNPO2	596	Q9UMS6
FSAMTQNPRPGSPLR	REV3L	1956	O60673
VPQTMSSHPRQAPER	RNF111	791	Q6ZNA4
TRGPAPSAMPQSRST	SPTBN2	2186	O15020
PMRPVRPVVQHRSSS	SRGAP3	1056	O43295
LPTQPPTRKMLTSRA	SSC4D	161	Q8WTU2
SRQAPLSMAAIRPEP	SH3RF3	806	Q8TEJ3
NISTAPPRRSMPAVI	SUSD1	371	Q6UWL2
PNPVAMETRSDNRPS	SAP130	466	Q9H0E3
PSTSPQMGRRTPAQV	FAM90A2P	341	Q658T7
RSLSFSEPQQPAPAM	ZNF395	446	Q9H8N7
RFTPMPSTPRVQQAQ	TROAP	356	Q12815
RSDSAPPTPVNRLSM	RALGAPB	356	Q86X10
NHLRRTMSVQQPDPP	PITPNM3	921	Q9BZ71
TMPRLGTSATTNPPR	PIGO	601	Q8TEQ8
RNPPAMSPAGQLSRT	TBXA2R	271	P21731
MSSVQQQPPPPRRVT	WASL	1	O00401
MQRPSLPDLSRPNTT	WIPF2	151	Q8TF74
SPRAPPMNILSAVIT	SLC26A7	296	Q8TE54
RSVSLTPPMNVPNQP	SAMD4A	251	Q9UPU9
VVMTPPRNRTLPDLS	ULK1	651	O75385
MRLSSSPPRGPQQLS	VENTX	1	O95231
PVPQRSMAVSQPNLV	WWTR1	176	Q9GZV5
QPALLPMSSNTFPSR	LCP2	331	Q13094
SMARPPLPRQQSTSS	MYO1E	991	Q12965
PSTNRSGPSQMALLP	MYRF	916	Q9Y2G1